181 related articles for article (PubMed ID: 11503255)
1. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
Knapik-Kordecka M; Adamiec R; Ciosek W
Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
[TBL] [Abstract][Full Text] [Related]
2. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelin-1 levels in patients with "a frigore" vascular acrosyndromes.
Mangiafico RA; Malatino LS; Spada RS; Santonocito M
Panminerva Med; 1996 Dec; 38(4):229-33. PubMed ID: 9063031
[TBL] [Abstract][Full Text] [Related]
4. [Serum endothelin in patients with Raynaud syndrome before and following cold provocation].
von Bierbrauer A; Herzog U; Ehlenz K; Wichert P
Vasa Suppl; 1991; 33():156-7. PubMed ID: 1788654
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
Edwards CM; Marshall JM; Pugh M
Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
Czupryniak A; Kałuzyńska A; Nowicki M; Wiecek B; Bald E; Owczarek D
Kidney Blood Press Res; 2005; 28(1):27-31. PubMed ID: 15452382
[TBL] [Abstract][Full Text] [Related]
7. Blood endothelin-1 and cold-induced vasodilation in patients with primary Raynauld's phenomenon and workers with vibration-induced white finger.
Nakamura H; Matsuzaki I; Hatta K; Nagase H; Nobokuni Y; Kambayashi Y; Ogino K
Int Angiol; 2003 Sep; 22(3):243-9. PubMed ID: 14612851
[TBL] [Abstract][Full Text] [Related]
8. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
[TBL] [Abstract][Full Text] [Related]
9. [Plasma endothelin concentration during cold provocation in primary Raynaud's syndrome].
von Bierbrauer A; Ehlenz K; Herzog P; Cassel W; von Wichert P
Dtsch Med Wochenschr; 1995 Jun; 120(25-26):902-6. PubMed ID: 7600925
[TBL] [Abstract][Full Text] [Related]
10. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.
Blann AD; Illingworth K; Jayson MI
J Rheumatol; 1993 Aug; 20(8):1325-30. PubMed ID: 8230013
[TBL] [Abstract][Full Text] [Related]
12. [Endothelin, endothelial cells and von Willebrand factor in peripheral blood of asthmatic patients].
Krasnowska M; Nittner-Marszalska M; Krasnowski R; Kopeć W
Pol Merkur Lekarski; 2002 Jun; 12(72):445-8. PubMed ID: 12362657
[TBL] [Abstract][Full Text] [Related]
13. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis.
Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK
Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448
[No Abstract] [Full Text] [Related]
15. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
Kahaleh MB; Osborn I; LeRoy EC
Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
[TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
17. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.
Cimminiello C; Milani M; Uberti T; Arpaia G; Perolini S; Bonfardeci G
Lancet; 1991 Jan; 337(8733):114-5. PubMed ID: 1670699
[No Abstract] [Full Text] [Related]
18. Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon.
Leppert J; Ringqvist A; Karlberg BE; Ringqvist I
Clin Physiol; 1998 Sep; 18(5):420-5. PubMed ID: 9784937
[TBL] [Abstract][Full Text] [Related]
19. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
[TBL] [Abstract][Full Text] [Related]
20. A pathogenic role for endothelin in Raynaud's phenomenon?
Bottomley W; Goodfield M
Acta Derm Venereol; 1994 Nov; 74(6):433-4. PubMed ID: 7701873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
